Literature DB >> 27160381

Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them.

Silvio Garattini1, Janus C Jakobsen2, Jørn Wetterslev3, Vittorio Bertelé4, Rita Banzi5, Ana Rath6, Edmund A M Neugebauer7, Martine Laville8, Yvonne Masson9, Virginie Hivert10, Michaela Eikermann11, Burc Aydin12, Sandra Ngwabyt13, Cecilia Martinho14, Chiara Gerardi15, Cezary A Szmigielski16, Jacques Demotes-Mainard17, Christian Gluud18.   

Abstract

Using the best quality of clinical research evidence is essential for choosing the right treatment for patients. How to identify the best research evidence is, however, difficult. In this narrative review we summarise these threats and describe how to minimise them. Pertinent literature was considered through literature searches combined with personal files. Treatments should generally not be chosen based only on evidence from observational studies or single randomised clinical trials. Systematic reviews with meta-analysis of all identifiable randomised clinical trials with Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment represent the highest level of evidence. Even though systematic reviews are trust worthier than other types of evidence, all levels of the evidence hierarchy are under threats from systematic errors (bias); design errors (abuse of surrogate outcomes, composite outcomes, etc.); and random errors (play of chance). Clinical research infrastructures may help in providing larger and better conducted trials. Trial Sequential Analysis may help in deciding when there is sufficient evidence in meta-analyses. If threats to the validity of clinical research are carefully considered and minimised, research results will be more valid and this will benefit patients and heath care systems.
Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Evidence-based clinical practice; Evidence-based medicine; Meta-analysis; Randomised clinical trial; Systematic review; Trial Sequential Analysis

Mesh:

Year:  2016        PMID: 27160381     DOI: 10.1016/j.ejim.2016.03.020

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  43 in total

1.  Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.

Authors:  João Q Coentro; Andrea De Pieri; Diana Gaspar; Dimitrios Tsiapalis; Dimitrios I Zeugolis; Yves Bayon
Journal:  J Mater Sci Mater Med       Date:  2019-12-02       Impact factor: 3.896

Review 2.  Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janette Greenhalgh; Juliet Hounsome; Naqash J Sethi; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

Review 3.  Nutrition support in hospitalised adults at nutritional risk.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Steven Kwasi Korang; Kirstine Halberg Engell; Marie Skøtt Nielsen; Kang Zhang; Maria Didriksen; Lisbeth Lund; Niklas Lindahl; Sara Hallum; Ning Liang; Wenjing Xiong; Xuemei Yang; Pernille Brunsgaard; Alexandre Garioud; Sanam Safi; Jane Lindschou; Jens Kondrup; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-05-19

Review 4.  Direct-acting antivirals for chronic hepatitis C.

Authors:  Janus C Jakobsen; Emil Eik Nielsen; Joshua Feinberg; Kiran Kumar Katakam; Kristina Fobian; Goran Hauser; Goran Poropat; Snezana Djurisic; Karl Heinz Weiss; Milica Bjelakovic; Goran Bjelakovic; Sarah Louise Klingenberg; Jian Ping Liu; Dimitrinka Nikolova; Ronald L Koretz; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

5.  Research Design Options for Intervention Studies.

Authors:  Michele A Lobo; Sarah H Kagan; John D Corrigan
Journal:  Pediatr Phys Ther       Date:  2017-07       Impact factor: 3.049

Review 6.  Direct-acting antivirals for chronic hepatitis C.

Authors:  Janus C Jakobsen; Emil Eik Nielsen; Joshua Feinberg; Kiran Kumar Katakam; Kristina Fobian; Goran Hauser; Goran Poropat; Snezana Djurisic; Karl Heinz Weiss; Milica Bjelakovic; Goran Bjelakovic; Sarah Louise Klingenberg; Jian Ping Liu; Dimitrinka Nikolova; Ronald L Koretz; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2017-06-06

Review 7.  Beta-blockers in patients without heart failure after myocardial infarction.

Authors:  Sanam Safi; Naqash J Sethi; Steven Kwasi Korang; Emil Eik Nielsen; Joshua Feinberg; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-05

Review 8.  Vitamin D supplementation for chronic liver diseases in adults.

Authors:  Milica Bjelakovic; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2021-08-25

Review 9.  Thrombolysis for acute upper extremity deep vein thrombosis.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-11

10.  Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit.

Authors:  Marija Barbateskovic; Olav L Schjørring; Sara Russo Krauss; Janus C Jakobsen; Christian S Meyhoff; Rikke M Dahl; Bodil S Rasmussen; Anders Perner; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.